Eurizon Capital SGR S.p.A. Takes Position in The Clorox Company $CLX

Eurizon Capital SGR S.p.A. acquired a new stake in The Clorox Company (NYSE:CLX) in the 4th quarter, HoldingsChannel reports. The fund acquired 130,193 shares of the company’s stock, valued at approximately $13,122,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Wilkins Investment Counsel Inc. lifted its holdings in shares of Clorox by 250.6% in the 4th quarter. Wilkins Investment Counsel Inc. now owns 55,064 shares of the company’s stock valued at $5,552,000 after buying an additional 39,360 shares during the period. ProShare Advisors LLC raised its holdings in Clorox by 11.7% in the 3rd quarter. ProShare Advisors LLC now owns 1,297,016 shares of the company’s stock worth $159,922,000 after purchasing an additional 136,135 shares during the period. JPMorgan Chase & Co. raised its holdings in Clorox by 27.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 928,654 shares of the company’s stock worth $114,506,000 after purchasing an additional 197,330 shares during the period. Morningstar Investment Management LLC raised its holdings in Clorox by 131.8% in the 4th quarter. Morningstar Investment Management LLC now owns 62,454 shares of the company’s stock worth $6,297,000 after purchasing an additional 35,506 shares during the period. Finally, Swiss Life Asset Management Ltd raised its holdings in Clorox by 221.4% in the 3rd quarter. Swiss Life Asset Management Ltd now owns 86,426 shares of the company’s stock worth $10,656,000 after purchasing an additional 59,533 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insider Buying and Selling

In other news, Director Pierre R. Breber acquired 5,000 shares of the business’s stock in a transaction on Tuesday, May 5th. The stock was bought at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the purchase, the director owned 18,000 shares in the company, valued at approximately $1,544,760. This represents a 38.46% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 0.63% of the company’s stock.

Clorox Price Performance

NYSE:CLX opened at $89.98 on Monday. The Clorox Company has a 12 month low of $84.70 and a 12 month high of $132.03. The stock has a 50 day moving average of $98.46 and a two-hundred day moving average of $105.82. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03. The firm has a market cap of $10.88 billion, a P/E ratio of 14.61, a price-to-earnings-growth ratio of 0.47 and a beta of 0.56.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping the consensus estimate of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same period in the previous year, the business earned $1.45 EPS. Clorox’s quarterly revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, analysts expect that The Clorox Company will post 5.61 earnings per share for the current fiscal year.

Analysts Set New Price Targets

CLX has been the subject of a number of analyst reports. Wall Street Zen raised Clorox from a “sell” rating to a “hold” rating in a report on Saturday, February 7th. JPMorgan Chase & Co. reduced their price target on Clorox from $99.00 to $95.00 and set an “underweight” rating for the company in a report on Friday, May 1st. Weiss Ratings raised Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, April 13th. Rothschild & Co Redburn set a $117.00 price target on Clorox in a report on Friday, February 13th. Finally, UBS Group reduced their price target on Clorox from $110.00 to $96.00 and set a “neutral” rating for the company in a report on Friday, May 1st. One investment analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have issued a Sell rating to the company’s stock. According to MarketBeat.com, Clorox has a consensus rating of “Reduce” and a consensus price target of $103.40.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.